Plasma β-Glucuronidase Levels in Breast Cancer by Whitaker, B. L.
471
PLASMA .-GLUCURONIDASE LEVELS IN BREAST CANCER
B. L. WHITAKER
From the Royal Free Hospital, London, W.C.1
Received for publication Julv 29, 1960
IT has been established by Kerr and Levvy (1947) and Levvy, Kerr aiid
Campbell (1948) that there is a connection between the level oftissue,8-glueuroili-
dase and processes ofgrowth and repair.
Fishman, Kasdon, Bonner, Fishman aiid Homburger (1951) have shown that
alterations in the hormonal state of the subject may have a profound effect oii
the level of the enzyme in the blood and tissues.
The blood level of 8-glucuronidase in 23 patients with breast cancer has beeii
investigatedby Cohen andHuseby (I951) who found the difference between normal
controls and cancerous subjects to be barely significant.
Goldbarg, Pineda, Banks and Rutenberg (1959) however found raised blood
levels in 14 out of 21 cases of breast cancer especially in those with liver second-
aries.
Boylaiid, Gasson and Williams (1957) observed high 8-glucuronidase levels
in the urine ofpatients with malignant disease, including carcinoma of the breast.
The present work deals with the plasma 8-glucuronidase levels in a series of
47 patients suffering from malignant disease of the breast and also with factors
which may have influenced these levels.
METHOD
Blood was taken into oxalate bottles. the plasma separated as soon as possible
and stored in rubber stoppered glass tubes at -20' C. for periods of 1-5 days.
In order to minimize diurnal variation the specimens were collected whenever
possible at the same time ofday, namely 1.30 p.m.
The loss of activity of the enzyme due to storage was of the order of I0 per
cent over 7 days.
The method of estimation has been that of Tallalay, Fishman and Huggii-is
(1946) as modified by Boyland, Wallace and Williams (1955) and Boyland, Gasson
and Williams (1957). The substrate, phenolphthalein mono-,d-glucuronic acid
(0-05 g. Sigma) was dissolved in 20 ml. ethanol and diluted to 100 ml. with water.
Theplasmaspecimens were diluted I in 10 with water immediately before incuba-
tion. Diluted plasma (I ml.), substrate solution (I ml.) and acetate buffer (I ml.,
0-1 m pH 4-5) were incubated in duplicate stoppered tubes at 37' C. for 16 hoiirs.
A blank containing no plasma was incubated. At the end of incubation I ml. of
10 per cent Na2CO3 solution was added to each tube and I ml. of diluted plasma
to the blank. The tubes were centrifuged for ten minutes at 3000 r.p.m. and read
against the blank on a Unicam S.P. 500spectrophotometer at550m/,t. Theactivity
was expressed in units, I unit liberatingI pg. ofphenolphthalein per ml. ofplasma
per hour at 37' C.472 B. L. WHITAKER
MATERIAL
Fifty iiormal women aiid 47 patients suffering from breast carcinoma were
studied. A total of 368 estimations was performed on these subjects both before
and after treatment. Oiie hundred and ninety-three of these estimations were
performed before the patients received treatment (apart fromandrogens which in
mai-iy c,,-ises had been given before the patient was referred, and operative pro-
cedures such as removal of the primary lesion which in some cases had beeii
performed many years before) and these 193 estimations form the basis of this
report. It is hoped to publish the findings with regard to the effect of treatment
oi-i the enzyme levels in a later report.
1. -.27ormal control8.-Fifty normal women aged from 18 to 70 years served as
controls (Table 1). Thirty-four of these were hospital patients about to undergo
operatioii for hernias, varicose veins, etc. The remainder were students and
members of the hospital staff. Thirty of the 50 were premenopausal and 20
menopausal or postmenopausal. The overall mean value of 8-glueuronidase for
these 50 individuals was 3-58 units and the standard deviation 1-31. The normal
range was taken as ±2o- from the mean, i.e. 0-96 to 6-20 units.
The meaii values for the pre- andpostmenopausal groups were almost identical
being 3-57 and 3-59 respectively.
2. Ca8e,3 ofbreast cancer.-The enzyme levels and relevant clinical details for the
47 cases of breast cancer are summarized in Table 11. The mean,8-glucuronidase
for this group irrespective of staging or previous therapy is 6-90 units (standard
deviation 3-87). This figure is significantly greater than the mean value of the
coiitrol group (c
= 5-63 P < 0-0000001). Fifty-one per cent of these cases
had eiizyme levels within the normal range and 49 per cent had elevated readings.
Analy8is of c",3es
An aiialysis of these figures was undertaken in aii attempt to correlate theni
with the clinical and pathological findings in individual cases. The results are
expressed graphically in Fig. 1.
(a) C'Unical -staging.-Of the 47 cases 10 (21-25 per cent) were clinically classed
as stage I or 11 (Table 11). The mean value for this group is 6-13 units (standard
deviation 4-07). A comparison ofthis with the control group shows the difference
to be significant (t 3-67 P < 0.001).
The remaining 37 cases were classed as stage III or IV and the mean value
for this group is 7-11 (standard deviation 3-84). Comparison with the control
group gives a value for c of 5-35 and for P of < 0.0000001.
Comparisoi-i of the stage III and 11" group with the stage I and 11 group however shows a difference in means ofonly 0-98. This does iiot attain statistical
significance (t 0-71 P < 0-5).
(b) Preiious hormone therapy.-Of the 37 cases in the stage III and IV group
20 had received treatment with androgenic hormones usually methyl testosterone
by mouth or testosterone propionate by injection at some time in the course of
their disease.
Cases 31, 33, 34, and 38 in the androgen treated group and 32, 35, 36, and 37
in the non-treated group had clinical evidence of liver involvement at the time
of the estimations and are excluded. This leaves for comparison 16 treated and
13 untreated cases. The mean values of #-glueuronidase for these two groups473 GLUCURONIDASE LEVELS IN BREAST CANCER
are 7-99 and 5-61 units respectively. With the number of cases available this
does not indicate a significant difference (t 1-56, P < 0-2).
(c) Hepatic involvement.-Twenty-nine of the 37 cases in the stage III and IV
group had no clinical or laboratory evidence of liver damage. Nine cases had
either enlarged livers, jaundice or abnormal liver function tests. In one case
(No. 26) observations were made both before and after thedevelopment ofsigns of
liver metastasis and she is therefore included in both groups.
TABLE I.-Normal Contro18
Control
number
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
Relation to
menopause
Premenopausal
Postmenopausal
9 31
Premenopausal
Postmenopausal
Menopausal
Postmenopausal
Menopausal
Postmenopausal
11 91
Premenopausal
Postmenopausal
Premenopausal
Menopausal
Premenopausal
Postmenopausal
Menopausal
Premenopausal
Postmenopausal
Premenopausal
Postmenopausal
Premenopausal
Postmenopausal
Premenopausal
Postmenopausal
Premenopausal
Postmenopausal
Number of
readings
1
.I
1
3
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Mean
fl-glucuronidase
4- 30
1-85
1-27
1-40
3-13
2-25
2-48
3- 24
3-40
3-16
3- 51
2- 75
5- 01
3- 86
4-53
2- 75
2- 32
1- 97
4- 87
4- 60
2- 35
3- 80
3- 36
1- 67
4-95
5- 00
2-44
3-95
3- 66
3- 86
3-90
3- 90
2-32
4- 60
6- 20
3- 20
4-50
8- 50
4- 85
4- 20
2-44
5- 05
4-10
2
- 73
4-00
3
- 86
3- 30
2-00
4- 61
2
- 84
Age
30
37
22
18
21
22
28
25
32
32
27
22
39
31
62
63
44
55
52
55
53
63
65
40
70
21
55
21
21
21
18
62
52
28
54
57
29
39
28
22
40
57
51
49
37
46
39
61
29
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The mean 8-glucuronidase level of the group without liver secondaries was
6-93 and of the other group 7-26. This difference is not significant (t
= 0-34,
P < 0-8). Five of the cases in the hepatic group were actually jaundiced at
one stage of their disease. The mean value for this group (No. 26, 32, 34, 37 and
TABLEII.-Breast Cancer
Number
of Mean
read- fl-glueu-
Histology ings ronidase
Spheroidal I 10
-47'
11. I 14- 70
91 9 I 4- 85
Poorly diff. 1 5-91 .Stage I
I 3- 70
Mucoid. 1 2- 42
Scirrhous I 1- 85
Relation
Case to Androgen Hepatic
number Age menopause therapy metastasis
I 80 Post.
2 48 Men.
3 55 Post.
4 71
5 - 68
6 59
7 71
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
26b
48 9 9
34 Pre.
34 9 .
47 519,
49 519
55 Post.
76 115,
51
54
35 Pre.
52 Men.
42 Pre.
46 Rad. men.
79 Post.
37 Rad. men.
78 Post.
58
73
32 Pre.
56 Men.
65 Post.
49 Pre.
54 Post.
47 Pre.
48 Post.
54 511,
52 519
55 519,
58 51
53 91
43 Post-hypo.
47 Pre.
65 Post.
58
52
59
45
63
62
54
I
I
1
4
3
2
8
3
4
4
1
1
6
2
2
10
2
8
5
4
1
3
3
5
2
10
1
2
5
3
5
4
3
1
2
6
1
6
1
2
2
Spheroidal
Anaplastic
Not known
Undiff.
Spheroidal
Scirrhous
Not known
Undiff.
Scirrhous
Anaplastic
Not known
Scirrhous
Spheroidal
Not known
Spheroidal
Anaplastic
Not known
91 91 31 I
Scirrhous
Not known
Scirrhous
Paget's and
scir.
Not known
Anaplastic
Scirrhous
Not known
Spheroidal
scirrhous
Mucoid
Not known
1 9 91 I
51
ewrhous
simplex
7
- 70
2
- 43 Stage 11
7
- 25
2-55'
1.90
3-50
5- 87
4- 84
18- 62
18- 80
5.05
9.00
7
- 32
4- 12
11-50
7
- 52
5-27
5- 79
4- 32
3- 67
10- 25
11- 25 Stages III 4- 05 and IV 6-58
4- 73
7
- 99
6- 60
4- 72
8- 83
12- 90
9- 85
4- 36
4- 57
4- 33
8- 80
9-44
7
-00
6- 66
4- 00
6- 35
6- 6238) during the jaundiced period was 8-59 which of course, for so few cases is not
outside the range of chance deviation.
(d) M4010gy.-The histology of the lesion was known in 34 of the 47 cases.
Twenty-one of these were described as anaplastic and the remainder were scir-
rhous carcinomas of varying degrees of differentiation. The mean values of
glucuronidase for the two groups are 7-41 and 5-16 (t 1-76, P < 0-1).
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FIG. I.-Comparison of plasma fl-glueuronidase levels of 50 normal women with 47 cases of
breast cancer. The dotted horizontal line represents the mean value for the control group and the upper and lower continuous lines two standard deviations around this mean.
DISCUSSION
The difference in levels between cancerous and non-cancerous individuals in
this series is highly significant. This corresponds with the findings of Goldbarg, Pineda, Banks and Rutenburg (1959), but not with those of Cohen and Huseby (1951).
The reason for this discrepancy between different workers is not clear. The
method used by Cohen and Huseby (1951) is that of Tallalay, Fishman and
Huggins (1946) while Goldbarg, Pineda, Banks and Rutenburg (1959) used 6-
bromo-2-naphthyl,fl-D-glucopyruronoside as a substrate.
The method used in the present series is a modification of the method of
Tallalay, Fishman and Huggins (1946) suggested by Boyland, Wallace and
Williams (1955).
The estimations have been carried out on oxalatedplasma without the addition
ofprotein precipitating agents such as the trichloracetic acid advocated by Fish-476 B. L. WHITAKER
man, Springer and Brunetti (1948) and also usedbyGoldbarg, Pineda, Banks and
Rutenburg (I959).
The difference in means between the stage I and II group and the stage III
and IV group is not sufficiently large in relation to the number of cases to be
outside the range of chance but serial observations on individual patients have
frequently demonstrated a rising titre corresponding to deterioration in clinical
state. Such a case is illustrated in Fig. 2.
I
took place cnday32
71
DAYS
FIG. 2'.-Serial estimations ofplasma fl-glueuronidase (case 23) showing rise in levels
with advance in disease process.
It seemslikely that withlarger numbers of cases thisgradient will attainsigni- ficant proportions.
Thefindings withregard to hepatic metastasis do not correspond with those of
Goldbarg, Pineda, Banks and Rutenburg (1959) who found raised levels in a
majority of cases of hepatic metastasis from breast cancer. Though in the
5 jaundiced cases very high levels were seen which sug.gest again that with a
larger number of cases the difference might be significant. The correlation with histological grading is of interest, suggesting as it does,
the possibility that there may be less 8-glueuronidase activity in those patients with scirrhous types ofgrowth.
The question of hormonal effects on tumours and on fl-glueuronidase is ofGLUCURONI'DASE LEVELS IN BREAST CANCER 477
considerable complexity and these results do not as yet allow of any but the
most tentative suggestions as to their relationship. It is perhaps of interest,
however, to note that the ratio of normal to abnormal levels in the cancer group
(51 and 49 per cent) is not very far removed from the percentagesgiven by Baron,
Gurling and Radley-Smith (1958) and Luft, Olivecrona, Ikkos, Nilsson and
Ljunggren (1956) for remissions and failures following hypophysectomy. This
may of course be entirely coincidental but investigations are in progress to
ascertain whether any relationship exists.
SUMMARY
(1) An investigation into the plasma 8-glucuronidase levels of 47 cases of
breast cancer and 50 normal women has been undertaken using a modification of
the method ofTallalay, Fishman and Huggins (1946).
(2) The difference between the enzyme levels of the cancerous and non-
cancerous groups was highly significant.
(3) Stage I and II carcinomas were associated with significantly raised enzyme
levels. Stage III and IV cases had higher mean values than Stage I and 11
but the difference was within the range of chance.
(4) Cases who had received androgen therapy had somewhat higher mean
values than those who had not had androgens and those with anaplastic growths had higher values than those with scirrhous but chance variation cannot be ex-
cluded as a cause for this.
(5) No great difference in enzyme levels could be demonstrated between cases
with and without hepatic metastasis in the absence ofjaundice.
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